Skip to content

Cardiac magnetic resonance study of dilated cardiomyopathy

Cardiac magnetic resonance study of dilated cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125193
Enrollment
Unknown
Registered
2026-05-22
Start date
2024-06-15
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dilated cardiomyopathy

Interventions

Observation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. According to the "Chinese Guidelines for the Diagnosis and Treatment of Dilated Cardiomyopathy": "(1) Left ventricular end-diastolic diameter (LVEDd) >5.0 cm (female) and LVEDd >5.5 cm (male) (or greater than 117% of the predicted value based on age and body surface area, i.e., 2 SD above the predicted value 5%); (2) LVEF <45% (Simpson's method), LVFS <25%; (3) Excluding hypertension, valvular heart disease, congenital heart disease, or ischemic heart disease at onset" confirms the diagnosis of DCM.

Exclusion criteria

Exclusion criteria: 1.Arrhythmia; 2.Poor image quality; 3.Combined with other primary cardiomyopathies.

Design outcomes

Primary

MeasureTime frame
the composite clinical outcome ;

Secondary

MeasureTime frame
pulmonary transit time;late gadolinium enhancement;ejection fraction;myocardial mass;ventricular diameter;

Countries

China

Contacts

Public ContactZhenlin Li

West China Hospital of Sichuan University, Chengdu

HX_lizhenlin@126.com+86 189 8060 2130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026